Wesley D. Sterman
Amministratore Delegato presso Signature Therapeutics, Inc.
Profilo
Wesley D.
Sterman founded Heartport, Inc. in 1991 and served as the President & Chief Executive Officer until 2011.
He also founded Innoviva, Inc. in 1996.
Dr. Sterman is also the founder of EndoVascular Technologies, Inc. Dr. Sterman's current job is as the President, Chief Executive Officer & Director at Signature Therapeutics, Inc. Dr. Sterman obtained an MBA and a doctorate from Stanford University.
Posizioni attive di Wesley D. Sterman
| Società | Posizione | Inizio |
|---|---|---|
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Amministratore Delegato | 28/06/2011 |
Precedenti posizioni note di Wesley D. Sterman
| Società | Posizione | Fine |
|---|---|---|
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Amministratore Delegato | 28/04/2011 |
| INNOVIVA, INC. | Fondatore | - |
EndoVascular Technologies, Inc.
 EndoVascular Technologies, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., EndoVascular Technologies, Inc. is a company that makes invasive endovascular systems. The company is based in Menlo Park, CA. The company was founded by Wesley D. Sterman. EndoVascular Technologies was acquired by Guidant Corp. on December 22, 1997 for $145.32 million. | Amministratore Delegato | - |
Formazione di Wesley D. Sterman
| Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Health Technology |
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Health Technology |
EndoVascular Technologies, Inc.
EndoVascular Technologies, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., EndoVascular Technologies, Inc. is a company that makes invasive endovascular systems. The company is based in Menlo Park, CA. The company was founded by Wesley D. Sterman. EndoVascular Technologies was acquired by Guidant Corp. on December 22, 1997 for $145.32 million. | Health Technology |
- Borsa valori
- Insiders
- Wesley D. Sterman
